Arthritis Research & Therapy | Articles which cite: Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study.

Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study.
Tebib J, Mariette X, Bourgeois P, Flipo RM, Gaudin P, Le Loët X, Gineste P, Guy L, Mansfield CD, Moussy A, Dubreuil P, Hermine O, Sibilia J
Arthritis Res Ther 2009, 11:R95
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]

printer friendly

to [Help]

BioMed Central articles that cite the above article:

Editorial

More about masitinib
Walker UA
Arthritis Research & Therapy 2009, 11:120 (13 July 2009)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]

You can also check ISI Web of Science for additional citations (subscription required)

printer friendly

to [Help]